These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6353660)

  • 41. [The evaluation in primary care of blood theophylline in patients with chronic obstructive pulmonary disease].
    Isanta Pomar C; Subías Lorén P; Baquer Masgrau A; Auría Romeo C; Martín Moros JM; Izquierdo Clemente C
    Rev Clin Esp; 1991 Jun; 189(1):42-3. PubMed ID: 1924930
    [No Abstract]   [Full Text] [Related]  

  • 42. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Theophylline dose-concentration relationship of a 12-hourly Nuelin SA regimen supplemented with nocturnal nuelin liquid in healthy volunteers.
    Schall R; Middle MV; Müller FO; du Plessis JB
    Chronobiol Int; 1993 Jun; 10(3):224-33. PubMed ID: 8319321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale].
    Cheng X; Yao Z; Li Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):84-7. PubMed ID: 10072830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 48. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

  • 49. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease.
    Crimi E; Orefice U; De Benedetto F; Grassi V; Brusasco V
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):501-8. PubMed ID: 7788518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
    Dull WL; Alexander MR; Sadoul P; Woolson RF
    Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double blind crossover randomised study of bromhexine in chronic obstructive airway disease.
    Misra MP; Tiwari UC; Chaubal CC; Galhotra R
    J Assoc Physicians India; 1984 May; 32(5):423-5. PubMed ID: 6389491
    [No Abstract]   [Full Text] [Related]  

  • 53. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
    Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical study of theophyllinemia in patients with obstructive bronchial syndrome].
    Vasiliev CB; Burnea D; Vasiliev R; Popescu C; Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(2):169-80. PubMed ID: 6316471
    [No Abstract]   [Full Text] [Related]  

  • 55. A study comparing Pro-Vent and phyllocontin in stable asthmatics.
    Sivananthan N; Kana D; Winson MD; Roberts KN
    Br J Clin Pract; 1988 Dec; 42(12):498-500. PubMed ID: 3076785
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of slow-release aminophylline on pulmonary function in obstructive respiratory disease(author's transl)].
    Wiessmann KJ
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1781-90. PubMed ID: 1098887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
    Alexander MR; Dull WL; Kasik JE
    JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of the effect of small dose of steroid to ephedrine--theophylline combination in chronic obstructive pulmonary disease.
    Kamat SR; Hoskote VR; Jagasia RS; Shah DC; Tyagi NK
    J Postgrad Med; 1983 Jul; 29(3):139-50. PubMed ID: 6655601
    [No Abstract]   [Full Text] [Related]  

  • 60. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin].
    Kandt D; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.